hengrui glp-1 Ribupatide, An Oral Dual GLP-1/GIP, Achieves Weight Loss in Phase 2 Obesity Trial Hengrui Pharma's GLP-1R Agonist Patent
Pay in 4 interest-free payments of $6.27 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2























